There is good reason to limit off-target drug delivery, to minimize side effects in tissues that don't need exposure to the drug.

• Is the oral route more effective than topical?
• What are the systemic effects of the oral med?
• Was the study quoted in the article in any way funded by a pharmaceutical company that would be granted an exclusive license for a "new formulation," or is it trustworthy?